1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
|
ID XP3OS
AC CVCL_3245
AS CVCL_F511
SY Xeroderma Pigmentosum 3 OSaka; GM04314; GM04314B; GM4314
DR CLO; CLO_0019557
DR Coriell; GM04314
DR GEO; GSM1338611
DR JCRB; JCRB0303
DR JCRB; KURB1002
DR JCRB; KURB1003
DR JCRB; KURB1004
DR Wikidata; Q54994928
RX CelloPub=CLPUB00447;
RX PubMed=832273;
RX PubMed=1372102;
RX PubMed=1702221;
RX PubMed=2570806;
RX PubMed=7000335;
RX PubMed=7830260;
RX PubMed=9671271;
RX PubMed=27197874;
CC Population: Japanese.
CC Sequence variation: Mutation; HGNC; 12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221; PubMed=9671271; PubMed=27197874).
CC Omics: Deep exome analysis.
CC Misspelling: XP30S; Note=Occasionally.
CC Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC Cell type: Fibroblast of skin; CL=CL_0002620.
ST Source(s): JCRB; PubMed=27197874
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 9,12
ST D18S51: 13
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 22,23
ST Penta D: 9
ST Penta E: 14,17
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI ORDO; Orphanet_910; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens (Human)
SX Female
AG 5Y
CA Finite cell line
DT Created: 04-04-12; Last updated: 29-06-23; Version: 20
//
ID 1-5c-4
AC CVCL_2260
SY Clone 1-5c-4; Clone 1-5c-4 WKD of Chang Conjunctiva; Wong-Kilbourne derivative of Chang conjunctiva; ChWK
DR CLO; CLO_0002500
DR CLO; CLO_0002501
DR CLDB; cl793
DR CLDB; cl794
DR CLDB; cl795
DR ATCC; CCL-20.2
DR BioSample; SAMN03151673
DR ECACC; 88021103
DR IZSLER; BS CL 93
DR KCLB; 10020.2
DR Wikidata; Q54399838
RX DOI=10.1007/BF02618370;
RX PubMed=566722;
RX PubMed=19630270;
RX PubMed=20143388;
WW https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=20143388). Originally thought to originate from the conjunctiva of a child.
CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00298.
CC Population: African American.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Transcriptome analysis by microarray.
CC Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,12
ST FGA: 18,21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens (Human)
HI CVCL_0030 ! HeLa
SX Female
AG 30Y6M
CA Cancer cell line
DT Created: 04-04-12; Last updated: 05-10-23; Version: 25
//
|
